HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Navabshan Irfan Selected Research

Sulfathiazole

5/2022Virtually screened novel sulfathiazole derivatives as a potential drug candidate for methicillin-resistant Staphylococcus aureus and multidrug-resistant tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Navabshan Irfan Research Topics

Disease

2Neoplasms (Cancer)
01/2022 - 11/2021
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
05/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1COVID-19
11/2021
1Urinary Tract Infections (Urinary Tract Infection)
06/2018
1Inflammation (Inflammations)
01/2016

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
05/2022 - 01/2022
1SulfathiazoleFDA Link
05/2022
1Virulence Factors (Pathogenicity Factors)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
11/2021
1Peptides (Polypeptides)IBA
11/2021
1Anti-Allergic Agents (Antiallergic Agents)IBA
11/2021
1QuinolonesIBA
06/2018
1DNA (Deoxyribonucleic Acid)IBA
06/2018
1FluoroquinolonesIBA
06/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2016